Published in

American Society for Clinical Investigation, Journal of Clinical Investigation, 7(133), 2023

DOI: 10.1172/jci165863

Links

Tools

Export citation

Search in Google Scholar

EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO